APVMA
  • Home
  • |
  • Publications
  • |
  • Forms
  • |
  • Media
  • |
  • Employment Opportunities
  • |
  • About Us
  • |
  • Contact Us
SearchSubmit
  • Search PUBCRIS for Registered Chemicals
  • |
  • Search for Permits
  • |
  • Ask a Question
Chemical Users
Community
Industry
Activities
  • Advice and application summaries
  • Active constituents
  • APVMA Gazette
  • Chemical reviews
  • Legislation
  • Quality assurance & compliance
  • Science Fellows

registrant component of the Adverse Experience Reporting Program for agricultural chemicals

Regulation Impact Statement - 28 June 2004

Following is the final Regulation Impact Statement (RIS) for the new 'registrant' component of the Adverse Experience Reporting Program for agricultural chemicals (AERP Ag).

The APVMA has consulted widely on this program and discussions were held with community groups, industry, medical representatives and farming bodies. A draft (or consultation) RIS was approved by the Office of Regulation Review (ORR) and published on the APVMA Website in March 2004. Comments were invited by 23 April 2004. In the draft RIS three options were proposed and discussed:

  • Option 1 - maintain the status quo with the current 'voluntary' and 'state' component of the AERP Ag,
  • Option 2 - establish a 'registrant' component of the AERP Ag, and
  • Option 3 - strengthen legislation.

This final RIS was prepared after consideration of the issues raised during the consultation phase, and was approved by the ORR in June 2004.

Regulation Impact Statement: Registrant component of the Adverse Experience Reporting Program for agricultural chemicals

See also:

Comments on the draft Regulation Impact Statement.

The three complementary components of the AERP Ag

Number of adverse experience reports involving pesticides by calendar year

The Registrant Component of the AERP Ag

Cost analysis of the 'registrant' component of the AERP Ag.

Algorithm for causality assessment of adverse experience reports involving agricultural products

Registrant's summary of reported adverse experiences form



  • Feedback
  • |
  • Subscribe to Mail List
  • |
  • Copyright
  • |
  • Privacy
  • |
  • Sitemap
  • |
  • Disclaimer